BAXTER INTERNATIONAL INC (1BAX.MI) Stock Fundamental Analysis

BIT:1BAX • US0718131099

17.766 EUR
-12.96 (-42.19%)
Last: Feb 9, 2026, 07:00 PM
Fundamental Rating

4

Taking everything into account, 1BAX scores 4 out of 10 in our fundamental rating. 1BAX was compared to 63 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of 1BAX have multiple concerns. 1BAX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • 1BAX had positive earnings in the past year.
  • 1BAX had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: 1BAX reported negative net income in multiple years.
  • 1BAX had a positive operating cash flow in each of the past 5 years.
1BAX.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

  • With a Return On Assets value of -2.52%, 1BAX perfoms like the industry average, outperforming 40.35% of the companies in the same industry.
  • 1BAX has a Return On Equity of -9.32%. This is comparable to the rest of the industry: 1BAX outperforms 40.35% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.45%, 1BAX is in line with its industry, outperforming 49.12% of the companies in the same industry.
  • 1BAX had an Average Return On Invested Capital over the past 3 years of 3.20%. This is significantly below the industry average of 9.98%.
  • The 3 year average ROIC (3.20%) for 1BAX is below the current ROIC(3.45%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.52%
ROE -9.32%
ROIC 3.45%
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
1BAX.MI Yearly ROA, ROE, ROIC1BAX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

  • With a Operating Margin value of 7.67%, 1BAX perfoms like the industry average, outperforming 56.14% of the companies in the same industry.
  • 1BAX's Operating Margin has declined in the last couple of years.
  • 1BAX's Gross Margin of 38.01% is on the low side compared to the rest of the industry. 1BAX is outperformed by 71.93% of its industry peers.
  • In the last couple of years the Gross Margin of 1BAX has declined.
Industry RankSector Rank
OM 7.67%
PM (TTM) N/A
GM 38.01%
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
1BAX.MI Yearly Profit, Operating, Gross Margins1BAX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1BAX is destroying value.
  • Compared to 1 year ago, 1BAX has more shares outstanding
  • Compared to 5 years ago, 1BAX has more shares outstanding
  • Compared to 1 year ago, 1BAX has a worse debt to assets ratio.
1BAX.MI Yearly Shares Outstanding1BAX.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1BAX.MI Yearly Total Debt VS Total Assets1BAX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • 1BAX has an Altman-Z score of 2.10. This is not the best score and indicates that 1BAX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • 1BAX has a Altman-Z score (2.10) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of 1BAX is 22.91, which is on the high side as it means it would take 1BAX, 22.91 years of fcf income to pay off all of its debts.
  • 1BAX's Debt to FCF ratio of 22.91 is in line compared to the rest of the industry. 1BAX outperforms 50.88% of its industry peers.
  • A Debt/Equity ratio of 1.79 is on the high side and indicates that 1BAX has dependencies on debt financing.
  • 1BAX has a worse Debt to Equity ratio (1.79) than 82.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF 22.91
Altman-Z 2.1
ROIC/WACC0.53
WACC6.49%
1BAX.MI Yearly LT Debt VS Equity VS FCF1BAX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • 1BAX has a Current Ratio of 1.36. This is a normal value and indicates that 1BAX is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.36, 1BAX perfoms like the industry average, outperforming 45.61% of the companies in the same industry.
  • A Quick Ratio of 1.05 indicates that 1BAX should not have too much problems paying its short term obligations.
  • 1BAX has a Quick ratio of 1.05. This is comparable to the rest of the industry: 1BAX outperforms 50.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.05
1BAX.MI Yearly Current Assets VS Current Liabilites1BAX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

3

3. Growth

3.1 Past

  • 1BAX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.37%.
  • 1BAX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.21% yearly.
  • 1BAX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.21%.
  • 1BAX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.31% yearly.
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.87% on average over the next years.
  • The Revenue is expected to grow by 5.61% on average over the next years.
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1BAX.MI Yearly Revenue VS Estimates1BAX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
1BAX.MI Yearly EPS VS Estimates1BAX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 7.25, which indicates a rather cheap valuation of 1BAX.
  • Based on the Price/Earnings ratio, 1BAX is valued cheaply inside the industry as 89.47% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.97. 1BAX is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 7.81 indicates a rather cheap valuation of 1BAX.
  • Based on the Price/Forward Earnings ratio, 1BAX is valued a bit cheaper than 75.44% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of 1BAX to the average of the S&P500 Index (27.96), we can say 1BAX is valued rather cheaply.
Industry RankSector Rank
PE 7.25
Fwd PE 7.81
1BAX.MI Price Earnings VS Forward Price Earnings1BAX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1BAX indicates a somewhat cheap valuation: 1BAX is cheaper than 78.95% of the companies listed in the same industry.
  • 73.68% of the companies in the same industry are more expensive than 1BAX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.58
EV/EBITDA 13.5
1BAX.MI Per share data1BAX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.96%
EPS Next 3Y3.75%

4

5. Dividend

5.1 Amount

  • 1BAX has a Yearly Dividend Yield of 2.17%.
  • Compared to an average industry Dividend Yield of 1.01, 1BAX pays a better dividend. On top of this 1BAX pays more dividend than 80.70% of the companies listed in the same industry.
  • 1BAX's Dividend Yield is comparable with the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

  • On average, the dividend of 1BAX grows each year by 6.89%, which is quite nice.
Dividend Growth(5Y)6.89%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1BAX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of 1BAX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-90.91%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
1BAX.MI Yearly Income VS Free CF VS Dividend1BAX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

BAXTER INTERNATIONAL INC

BIT:1BAX (2/9/2026, 7:00:00 PM)

17.766

-12.96 (-42.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-20
Earnings (Next)04-24
Inst Owners97.07%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap9.11B
Revenue(TTM)12.86B
Net Income(TTM)-649.00M
Analysts68.18
Price Target35.44 (99.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend1.05
Dividend Growth(5Y)6.89%
DP-90.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.32%
Min EPS beat(2)1.94%
Max EPS beat(2)10.69%
EPS beat(4)4
Avg EPS beat(4)5.06%
Min EPS beat(4)1.64%
Max EPS beat(4)10.69%
EPS beat(8)7
Avg EPS beat(8)3.73%
EPS beat(12)8
Avg EPS beat(12)2.99%
EPS beat(16)12
Avg EPS beat(16)4.13%
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-0.93%
Max Revenue beat(2)1.93%
Revenue beat(4)3
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)-0.57%
Revenue beat(12)4
Avg Revenue beat(12)-1.99%
Revenue beat(16)5
Avg Revenue beat(16)-2.54%
PT rev (1m)-3.81%
PT rev (3m)-3.81%
EPS NQ rev (1m)-31.48%
EPS NQ rev (3m)-31.48%
EPS NY rev (1m)-22.05%
EPS NY rev (3m)-22.05%
Revenue NQ rev (1m)-30.35%
Revenue NQ rev (3m)-30.35%
Revenue NY rev (1m)-28.82%
Revenue NY rev (3m)-28.82%
Valuation
Industry RankSector Rank
PE 7.25
Fwd PE 7.81
P/S 0.78
P/FCF 17.58
P/OCF 9.89
P/B 1.45
P/tB N/A
EV/EBITDA 13.5
EPS(TTM)2.45
EY13.79%
EPS(NY)2.28
Fwd EY12.81%
FCF(TTM)1.01
FCFY5.69%
OCF(TTM)1.8
OCFY10.11%
SpS22.67
BVpS12.28
TBVpS-6.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.52%
ROE -9.32%
ROCE 5.12%
ROIC 3.45%
ROICexc 3.76%
ROICexgc 8.07%
OM 7.67%
PM (TTM) N/A
GM 38.01%
FCFM 4.46%
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
ROICexc(3y)3.57%
ROICexc(5y)5.33%
ROICexgc(3y)9.57%
ROICexgc(5y)12.38%
ROCE(3y)4.43%
ROCE(5y)6.16%
ROICexgc growth 3Y-30.34%
ROICexgc growth 5Y-21.96%
ROICexc growth 3Y-22.52%
ROICexc growth 5Y-26.32%
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
F-Score3
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF 22.91
Debt/EBITDA 6.3
Cap/Depr 44.73%
Cap/Sales 3.47%
Interest Coverage 4.42
Cash Conversion 51.39%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.05
Altman-Z 2.1
F-Score3
WACC6.49%
ROIC/WACC0.53
Cap/Depr(3y)49.31%
Cap/Depr(5y)63.51%
Cap/Sales(3y)5.12%
Cap/Sales(5y)5.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%
EBIT growth 1Y-21.12%
EBIT growth 3Y-30.01%
EBIT growth 5Y-18.5%
EBIT Next Year69.69%
EBIT Next 3Y22.35%
EBIT Next 5Y25.92%
FCF growth 1Y-44.58%
FCF growth 3Y-27.1%
FCF growth 5Y-16.46%
OCF growth 1Y-40.96%
OCF growth 3Y-22.88%
OCF growth 5Y-13.5%

BAXTER INTERNATIONAL INC / 1BAX.MI FAQ

What is the ChartMill fundamental rating of BAXTER INTERNATIONAL INC (1BAX.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1BAX.MI.


Can you provide the valuation status for BAXTER INTERNATIONAL INC?

ChartMill assigns a valuation rating of 5 / 10 to BAXTER INTERNATIONAL INC (1BAX.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for BAXTER INTERNATIONAL INC?

BAXTER INTERNATIONAL INC (1BAX.MI) has a profitability rating of 3 / 10.


What is the valuation of BAXTER INTERNATIONAL INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BAXTER INTERNATIONAL INC (1BAX.MI) is 7.25 and the Price/Book (PB) ratio is 1.45.


Can you provide the dividend sustainability for 1BAX stock?

The dividend rating of BAXTER INTERNATIONAL INC (1BAX.MI) is 4 / 10 and the dividend payout ratio is -90.91%.